Go BACK

OUH STUDIES

Studies currently being run within Oxford University Hospitals NHS Foundation Trust.

Showing 541 - 550 of 764 studies

Blood

A Phase 3, Prospective, Open-label, Uncontrolled, Multicenter Study on Efficacy and Safety of Prophylaxis with rVWF in Children Diagnosed with Severe Von Willebrand Disease ( rVWF Pediatric Prophylaxis Study) (TAK-577-3001)

Cancer and neoplasms

A Randomized Phase 3 Trial of IMA203 PRAME-directed TCR T-cell Therapy vs Investigator’s Choice in Unresectable or Metastatic Melanoma post ICI (IMA203-301) (SUPRAME)

DPYD polymorphisms in patients with solid tumours receiving fluoropyrimidines: A UK clinical registry

Infection Reproductive health and childbirth

A Phase 3, Randomized, Placebo-Controlled, Double-Blinded Trial to Evaluate the Safety, Tolerability, and Immunogenicity of a Multivalent Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Infants (C1091009)

Cancer and neoplasms

A Phase II, Open-Label, Multicenter Study of Inobrodib in Combination with Pomalidomide and Dexamethasone in Patients with Relapsed or Refractory Multiple Myeloma (CCS1477-04)

Cancer and neoplasms

A Phase 3, Open-Label, Randomized Study to Evaluate the Safety and Efficacy of BGB-16673 Compared to Pirtobrutinib in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma (BGB-16673-304)

Cancer and neoplasms Metabolic and Endocrine

A PHASE 2/3, MULTICENTER, RANDOMIZED OPEN-LABEL STUDY OF ZANZALINTINIB VS EVEROLIMUS IN PARTICIPANTS WITH PREVIOUSLY TREATED, UNRESECTABLE, LOCALLY ADVANCED OR METASTATIC NEUROENDOCRINE TUMORS (XL092-311 (STELLAR-311))

Neurological

A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study To Evaluate The Efficacy And Safety Of Intravenous Prasinezumab In Participants With Early Parkinson’s Disease (BN44715 (PARAISO))

A qualitative study of parental views regarding a play-based intervention for supporting neurodevelopment in preschool aged children receiving systemic cancer therapy

Respiratory

A Phase 2b/3, randomized, double-blind, placebo-controlled, multicenter study, to investigate the efficacy and safety of lunsekimig compared with placebo in adult participants with moderate-to-severe chronic obstructive pulmonary disease with type 2 inflammation.. (PERSEPHONE)